Retraction
miR-361-5p inhibits hepatocellular carcinoma cell proliferation and invasion by targeting VEGFA
Paper Information
Record ID:
19918
Publication Date:
September 15, 2016
Retraction Date:
January 01, 2019
(6.9 years years ago)
Subjects:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.1016/j.bbrc.2018.11.194Additional Notes:
date of retraction unknown, html page overwrite, date estimated from notifications; separate notice issued later, on 6/22/2019;
Citations (23)
23
Total Citations18
Post-Retraction(78.3%)
5
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
7
Within 1 year
8
After 2+ years
1551
Days since retraction (latest)
Paper citing Chronic Inflammation: Accelerator of Biological Ag...
Unknown Authors
Unknown Journal
Published: Apr 2023
1551 days after retraction
Cross-regulation between microRNAs and key proteins of signaling pathways in hepatocellular carcinoma
Haihong Hu, Tao‐Lan Zhang, Yiwen Wu et al. (6 authors)
Expert Review of Gastroenterology & Hepatology
Published: Jul 2022
1290 days after retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Sep 2021
998 days after retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Aug 2021
965 days after retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Aug 2021
944 days after retraction
MicroRNA‑361‑5p induces hepatocellular carcinoma cell apoptosis and enhances drug sensitivity by targeting MAP3K9
Qingbo Ren, Xiangmei Xiao, Xiaoqian Leng et al. (7 authors)
Experimental and Therapeutic Medicine
Open Access
Published: Mar 2021
7 citations
7 citations
820 days after retraction
Dysregulation of serum miR-361-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients
Wenqing Zhang, Guannan Chang, Liya Cao et al. (4 authors)
BMC Cardiovascular Disorders
Open Access
Published: Feb 2021
18 citations
18 citations
766 days after retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Jan 2021
741 days after retraction
MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1
Liang-Chun Yin, Gang Xiao, Rui Zhou et al. (9 authors)
BioMed Research International
Open Access
Published: Dec 2020
18 citations
18 citations
716 days after retraction
miR-17-5p mitigates endometriosis by directly regulating VEGFA
Qin-Xia Pang, Zhou Liu
Journal of Biosciences
Published: Jun 2020
9 citations
9 citations
520 days after retraction
Delivery of thymoquinone through hyaluronic acid-decorated mixed Pluronic® nanoparticles to attenuate angiogenesis and metastasis of triple-negative breast cancer
Saurav Bhattacharya, Avijit Ghosh, Santanu Maiti et al. (11 authors)
Journal of Controlled Release
Published: Mar 2020
73 citations
73 citations
455 days after retraction
MiR-361-5p exerts tumor-suppressing functions in gastric carcinoma by targeting syndecan-binding protein
Bo Qian, Daoquan Zhang, Ran Tao et al. (9 authors)
Anti-Cancer Drugs
Published: Dec 2019
8 citations
8 citations
351 days after retraction
MicroRNA dysregulation interplay with childhood abdominal tumors
Karina Bezerra Salomão, Julia Alejandra Pezuk, Graziella Ribeiro de Sousa et al. (7 authors)
Cancer and Metastasis Reviews
Published: Dec 2019
14 citations
14 citations
334 days after retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Aug 2019
212 days after retraction
Paper citing miR-367 promotes proliferation and invasion of hep...
Unknown Authors
Unknown Journal
Published: Aug 2019
212 days after retraction
Retraction notice to “The miR-599 promotes non-small cell lung cancer cell invasion via SATB2” [Biochem. Biophys. Res. Commun. 485/1 (2017) 35–40]
Wenjun Tian, Guanghai Wang, Yiqing Liu et al. (13 authors)
Biochemical and Biophysical Research Communications
Published: Jun 2019
1 citation
1 citation
172 days after retraction
Long non-coding RNA NEAT1 promotes the progression of hemangioma via the miR-361-5p/VEGFA pathway
Xueyuan Yu, Xiangyu Liu, Rui Wang et al. (4 authors)
Biochemical and Biophysical Research Communications
Published: Mar 2019
18 citations
18 citations
85 days after retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Feb 2019
31 days after retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Nov 2018
61 days before retraction
RETRACTED: MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1
Rui Li, Bingfei Dong, Zhengmin Wang et al. (5 authors)
Biomedicine & Pharmacotherapy
Published: Apr 2018
19 citations
19 citations
270 days before retraction
The Role of MicroRNAs in Hepatocellular Carcinoma
Xin Xu, Yuquan Tao, Liang Shan et al. (9 authors)
Journal of Cancer
Open Access
Published: Jan 2018
159 citations
159 citations
365 days before retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Nov 2017
414 days before retraction
Paper citing miR-361-5p inhibits hepatocellular carcinoma cell ...
Unknown Authors
Unknown Journal
Published: Sep 2017
487 days before retraction
Quick Stats
Total Citations:
23
Years Since Retraction:
6.9 years
Open Access:
Yes
Last Checked:
Never